Research News

Microneedle patch for flu vaccination proves successful in human clinical trial

BMJ 2017; 357 doi: https://doi.org/10.1136/bmj.j3120 (Published 28 June 2017) Cite this as: BMJ 2017;357:j3120
  1. Jacqui Wise
  1. London

An influenza vaccine delivered by a dissolvable microneedle patch can produce robust immune responses and be successfully self applied, a human trial published in the Lancet has shown.1

The patch, which looks like a small sticking plaster or Band-Aid, has 100 water soluble microneedles that dissolve within minutes of insertion into the skin, releasing the vaccine. The patch can then be peeled away and discarded.

The phase I study found that the microneedle patch was stable for one year at 40°C, meaning that it could be distributed and stored outside the cold chain and potentially stored on a pharmacy …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe